The Evidence Based Rheumatology Podcast

← The Evidence Based Rheumatology Podcast19. März · 15 Min.

E133: Obinutuzumab for SLE (ALLEGORY)

E133: Obinutuzumab for SLE (ALLEGORY)19. März15 Min.

Good RCT this week, investigating the CD20 B cell inhibitor obinutuzumab for SLE. Sign up for my newsletter if you would like to have a read-along companion piece!

Paper: https://www.nejm.org/doi/full/10.1056/NEJMoa2516150

Landing Page: https://ebrheum.com/

Substack: https://autoimmunedevreport.substack.com/